10-Q 1 it-20240630.htm 10-Q it-20240630
00007492512024Q2false--12-3191http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#AccountsPayableAndAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccountsPayableAndAccruedLiabilitiesCurrentxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesit:segmentxbrli:pureit:contract00007492512024-01-012024-06-3000007492512024-07-2600007492512024-06-3000007492512023-12-310000749251it:ResearchRevenueMember2024-04-012024-06-300000749251it:ResearchRevenueMember2023-04-012023-06-300000749251it:ResearchRevenueMember2024-01-012024-06-300000749251it:ResearchRevenueMember2023-01-012023-06-300000749251it:ConferencesMember2024-04-012024-06-300000749251it:ConferencesMember2023-04-012023-06-300000749251it:ConferencesMember2024-01-012024-06-300000749251it:ConferencesMember2023-01-012023-06-300000749251it:ConsultingMember2024-04-012024-06-300000749251it:ConsultingMember2023-04-012023-06-300000749251it:ConsultingMember2024-01-012024-06-300000749251it:ConsultingMember2023-01-012023-06-3000007492512024-04-012024-06-3000007492512023-04-012023-06-3000007492512023-01-012023-06-300000749251us-gaap:CommonStockMember2023-12-310000749251us-gaap:AdditionalPaidInCapitalMember2023-12-310000749251us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000749251us-gaap:RetainedEarningsMember2023-12-310000749251us-gaap:TreasuryStockCommonMember2023-12-310000749251us-gaap:RetainedEarningsMember2024-01-012024-03-3100007492512024-01-012024-03-310000749251us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000749251us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310000749251us-gaap:TreasuryStockCommonMember2024-01-012024-03-310000749251us-gaap:CommonStockMember2024-03-310000749251us-gaap:AdditionalPaidInCapitalMember2024-03-310000749251us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310000749251us-gaap:RetainedEarningsMember2024-03-310000749251us-gaap:TreasuryStockCommonMember2024-03-3100007492512024-03-310000749251us-gaap:RetainedEarningsMember2024-04-012024-06-300000749251us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300000749251us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300000749251us-gaap:TreasuryStockCommonMember2024-04-012024-06-300000749251us-gaap:CommonStockMember2024-06-300000749251us-gaap:AdditionalPaidInCapitalMember2024-06-300000749251us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300000749251us-gaap:RetainedEarningsMember2024-06-300000749251us-gaap:TreasuryStockCommonMember2024-06-300000749251us-gaap:CommonStockMember2022-12-310000749251us-gaap:AdditionalPaidInCapitalMember2022-12-310000749251us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000749251us-gaap:RetainedEarningsMember2022-12-310000749251us-gaap:TreasuryStockCommonMember2022-12-3100007492512022-12-310000749251us-gaap:RetainedEarningsMember2023-01-012023-03-3100007492512023-01-012023-03-310000749251us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000749251us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000749251us-gaap:TreasuryStockCommonMember2023-01-012023-03-310000749251us-gaap:CommonStockMember2023-03-310000749251us-gaap:AdditionalPaidInCapitalMember2023-03-310000749251us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000749251us-gaap:RetainedEarningsMember2023-03-310000749251us-gaap:TreasuryStockCommonMember2023-03-3100007492512023-03-310000749251us-gaap:RetainedEarningsMember2023-04-012023-06-300000749251us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300000749251us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300000749251us-gaap:TreasuryStockCommonMember2023-04-012023-06-300000749251us-gaap:CommonStockMember2023-06-300000749251us-gaap:AdditionalPaidInCapitalMember2023-06-300000749251us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300000749251us-gaap:RetainedEarningsMember2023-06-300000749251us-gaap:TreasuryStockCommonMember2023-06-3000007492512023-06-300000749251it:A2022AcquisitionMember2024-04-012024-06-3000007492512023-02-012023-02-280000749251it:GartnerResearchProductsMember2023-09-300000749251it:GartnerResearchProductsMember2023-09-012023-09-300000749251it:GartnerResearchProductsMember2024-01-012024-06-300000749251it:TalentNeuronMember2023-02-280000749251it:TalentNeuronMember2023-01-012023-06-3000007492512023-07-012023-09-300000749251it:ResearchSegmentMember2023-12-310000749251it:ConferencesMember2023-12-310000749251it:ConsultingMember2023-12-310000749251it:ResearchSegmentMember2024-01-012024-06-300000749251it:ConferencesMember2024-01-012024-06-300000749251it:ConsultingMember2024-01-012024-06-300000749251it:ResearchSegmentMember2024-06-300000749251it:ConferencesMember2024-06-300000749251it:ConsultingMember2024-06-300000749251us-gaap:CustomerRelationshipsMember2023-12-310000749251us-gaap:ComputerSoftwareIntangibleAssetMember2023-12-310000749251us-gaap:OtherIntangibleAssetsMember2023-12-310000749251us-gaap:CustomerRelationshipsMember2024-01-012024-06-300000749251us-gaap:ComputerSoftwareIntangibleAssetMember2024-01-012024-06-300000749251us-gaap:OtherIntangibleAssetsMember2024-01-012024-06-300000749251us-gaap:CustomerRelationshipsMember2024-06-300000749251us-gaap:ComputerSoftwareIntangibleAssetMember2024-06-300000749251us-gaap:OtherIntangibleAssetsMember2024-06-300000749251us-gaap:CustomerRelationshipsMembersrt:MinimumMember2024-06-300000749251us-gaap:CustomerRelationshipsMembersrt:MaximumMember2024-06-300000749251srt:MaximumMemberus-gaap:OtherIntangibleAssetsMember2024-06-300000749251it:ResearchSegmentMemberit:UnitedStatesAndCanadaMember2024-04-012024-06-300000749251it:ConferencesMemberit:UnitedStatesAndCanadaMember2024-04-012024-06-300000749251it:UnitedStatesAndCanadaMemberit:ConsultingMember2024-04-012024-06-300000749251it:UnitedStatesAndCanadaMember2024-04-012024-06-300000749251it:EuropeMiddleEastAfricaMemberit:ResearchSegmentMember2024-04-012024-06-300000749251it:ConferencesMemberit:EuropeMiddleEastAfricaMember2024-04-012024-06-300000749251it:EuropeMiddleEastAfricaMemberit:ConsultingMember2024-04-012024-06-300000749251it:EuropeMiddleEastAfricaMember2024-04-012024-06-300000749251it:ResearchSegmentMemberit:OtherInternationalMember2024-04-012024-06-300000749251it:ConferencesMemberit:OtherInternationalMember2024-04-012024-06-300000749251it:OtherInternationalMemberit:ConsultingMember2024-04-012024-06-300000749251it:OtherInternationalMember2024-04-012024-06-300000749251it:ResearchSegmentMember2024-04-012024-06-300000749251it:ConferencesMember2024-04-012024-06-300000749251it:ConsultingMember2024-04-012024-06-300000749251it:ResearchSegmentMemberit:UnitedStatesAndCanadaMember2023-04-012023-06-300000749251it:ConferencesMemberit:UnitedStatesAndCanadaMember2023-04-012023-06-300000749251it:UnitedStatesAndCanadaMemberit:ConsultingMember2023-04-012023-06-300000749251it:UnitedStatesAndCanadaMember2023-04-012023-06-300000749251it:EuropeMiddleEastAfricaMemberit:ResearchSegmentMember2023-04-012023-06-300000749251it:ConferencesMemberit:EuropeMiddleEastAfricaMember2023-04-012023-06-300000749251it:EuropeMiddleEastAfricaMemberit:ConsultingMember2023-04-012023-06-300000749251it:EuropeMiddleEastAfricaMember2023-04-012023-06-300000749251it:ResearchSegmentMemberit:OtherInternationalMember2023-04-012023-06-300000749251it:ConferencesMemberit:OtherInternationalMember2023-04-012023-06-300000749251it:OtherInternationalMemberit:ConsultingMember2023-04-012023-06-300000749251it:OtherInternationalMember2023-04-012023-06-300000749251it:ResearchSegmentMember2023-04-012023-06-300000749251it:ConferencesMember2023-04-012023-06-300000749251it:ConsultingMember2023-04-012023-06-300000749251it:ResearchSegmentMemberit:UnitedStatesAndCanadaMember2024-01-012024-06-300000749251it:ConferencesMemberit:UnitedStatesAndCanadaMember2024-01-012024-06-300000749251it:UnitedStatesAndCanadaMemberit:ConsultingMember2024-01-012024-06-300000749251it:UnitedStatesAndCanadaMember2024-01-012024-06-300000749251it:EuropeMiddleEastAfricaMemberit:ResearchSegmentMember2024-01-012024-06-300000749251it:ConferencesMemberit:EuropeMiddleEastAfricaMember2024-01-012024-06-300000749251it:EuropeMiddleEastAfricaMemberit:ConsultingMember2024-01-012024-06-300000749251it:EuropeMiddleEastAfricaMember2024-01-012024-06-300000749251it:ResearchSegmentMemberit:OtherInternationalMember2024-01-012024-06-300000749251it:ConferencesMemberit:OtherInternationalMember2024-01-012024-06-300000749251it:OtherInternationalMemberit:ConsultingMember2024-01-012024-06-300000749251it:OtherInternationalMember2024-01-012024-06-300000749251it:ResearchSegmentMemberit:UnitedStatesAndCanadaMember2023-01-012023-06-300000749251it:ConferencesMemberit:UnitedStatesAndCanadaMember2023-01-012023-06-300000749251it:UnitedStatesAndCanadaMemberit:ConsultingMember2023-01-012023-06-300000749251it:UnitedStatesAndCanadaMember2023-01-012023-06-300000749251it:EuropeMiddleEastAfricaMemberit:ResearchSegmentMember2023-01-012023-06-300000749251it:ConferencesMemberit:EuropeMiddleEastAfricaMember2023-01-012023-06-300000749251it:EuropeMiddleEastAfricaMemberit:ConsultingMember2023-01-012023-06-300000749251it:EuropeMiddleEastAfricaMember2023-01-012023-06-300000749251it:ResearchSegmentMemberit:OtherInternationalMember2023-01-012023-06-300000749251it:ConferencesMemberit:OtherInternationalMember2023-01-012023-06-300000749251it:OtherInternationalMemberit:ConsultingMember2023-01-012023-06-300000749251it:OtherInternationalMember2023-01-012023-06-300000749251it:ResearchSegmentMember2023-01-012023-06-300000749251it:ConferencesMember2023-01-012023-06-300000749251it:ConsultingMember2023-01-012023-06-300000749251it:ResearchSegmentMemberus-gaap:TransferredOverTimeMember2024-04-012024-06-300000749251it:ConferencesMemberus-gaap:TransferredOverTimeMember2024-04-012024-06-300000749251us-gaap:TransferredOverTimeMemberit:ConsultingMember2024-04-012024-06-300000749251us-gaap:TransferredOverTimeMember2024-04-012024-06-300000749251us-gaap:TransferredAtPointInTimeMemberit:ResearchSegmentMember2024-04-012024-06-300000749251it:ConferencesMemberus-gaap:TransferredAtPointInTimeMember2024-04-012024-06-300000749251us-gaap:TransferredAtPointInTimeMemberit:ConsultingMember2024-04-012024-06-300000749251us-gaap:TransferredAtPointInTimeMember2024-04-012024-06-300000749251it:ResearchSegmentMemberus-gaap:TransferredOverTimeMember2023-04-012023-06-300000749251it:ConferencesMemberus-gaap:TransferredOverTimeMember2023-04-012023-06-300000749251us-gaap:TransferredOverTimeMemberit:ConsultingMember2023-04-012023-06-300000749251us-gaap:TransferredOverTimeMember2023-04-012023-06-300000749251us-gaap:TransferredAtPointInTimeMemberit:ResearchSegmentMember2023-04-012023-06-300000749251it:ConferencesMemberus-gaap:TransferredAtPointInTimeMember2023-04-012023-06-300000749251us-gaap:TransferredAtPointInTimeMemberit:ConsultingMember2023-04-012023-06-300000749251us-gaap:TransferredAtPointInTimeMember2023-04-012023-06-300000749251it:ResearchSegmentMemberus-gaap:TransferredOverTimeMember2024-01-012024-06-300000749251it:ConferencesMemberus-gaap:TransferredOverTimeMember2024-01-012024-06-300000749251us-gaap:TransferredOverTimeMemberit:ConsultingMember2024-01-012024-06-300000749251us-gaap:TransferredOverTimeMember2024-01-012024-06-300000749251us-gaap:TransferredAtPointInTimeMemberit:ResearchSegmentMember2024-01-012024-06-300000749251it:ConferencesMemberus-gaap:TransferredAtPointInTimeMember2024-01-012024-06-300000749251us-gaap:TransferredAtPointInTimeMemberit:ConsultingMember2024-01-012024-06-300000749251us-gaap:TransferredAtPointInTimeMember2024-01-012024-06-300000749251it:ResearchSegmentMemberus-gaap:TransferredOverTimeMember2023-01-012023-06-300000749251it:ConferencesMemberus-gaap:TransferredOverTimeMember2023-01-012023-06-300000749251us-gaap:TransferredOverTimeMemberit:ConsultingMember2023-01-012023-06-300000749251us-gaap:TransferredOverTimeMember2023-01-012023-06-300000749251us-gaap:TransferredAtPointInTimeMemberit:ResearchSegmentMember2023-01-012023-06-300000749251it:ConferencesMemberus-gaap:TransferredAtPointInTimeMember2023-01-012023-06-300000749251us-gaap:TransferredAtPointInTimeMemberit:ConsultingMember2023-01-012023-06-300000749251us-gaap:TransferredAtPointInTimeMember2023-01-012023-06-3000007492512024-07-012024-06-3000007492512025-01-012024-06-3000007492512026-01-012024-06-300000749251us-gaap:StockAppreciationRightsSARSMember2024-04-012024-06-300000749251us-gaap:StockAppreciationRightsSARSMember2023-04-012023-06-300000749251us-gaap:StockAppreciationRightsSARSMember2024-01-012024-06-300000749251us-gaap:StockAppreciationRightsSARSMember2023-01-012023-06-300000749251us-gaap:RestrictedStockUnitsRSUMember2024-04-012024-06-300000749251us-gaap:RestrictedStockUnitsRSUMember2023-04-012023-06-300000749251us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-06-300000749251us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-06-300000749251it:CommonStockEquivalentsMember2024-04-012024-06-300000749251it:CommonStockEquivalentsMember2023-04-012023-06-300000749251it:CommonStockEquivalentsMember2024-01-012024-06-300000749251it:CommonStockEquivalentsMember2023-01-012023-06-300000749251us-gaap:CostOfSalesMember2024-04-012024-06-300000749251us-gaap:CostOfSalesMember2023-04-012023-06-300000749251us-gaap:CostOfSalesMember2024-01-012024-06-300000749251us-gaap:CostOfSalesMember2023-01-012023-06-300000749251us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-04-012024-06-300000749251us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-04-012023-06-300000749251us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-012024-06-300000749251us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-06-300000749251it:RetirementEligibleEmployeesEquityAwardMember2024-04-012024-06-300000749251it:RetirementEligibleEmployeesEquityAwardMember2023-04-012023-06-300000749251it:RetirementEligibleEmployeesEquityAwardMember2024-01-012024-06-300000749251it:RetirementEligibleEmployeesEquityAwardMember2023-01-012023-06-300000749251us-gaap:IntersegmentEliminationMember2024-01-012024-06-300000749251us-gaap:OperatingSegmentsMemberit:ResearchSegmentMember2024-04-012024-06-300000749251it:ConferencesMemberus-gaap:OperatingSegmentsMember2024-04-012024-06-300000749251us-gaap:OperatingSegmentsMemberit:ConsultingMember2024-04-012024-06-300000749251us-gaap:OperatingSegmentsMember2024-04-012024-06-300000749251it:CorporateAndReconcilingItemsMember2024-04-012024-06-300000749251us-gaap:OperatingSegmentsMemberit:ResearchSegmentMember2023-04-012023-06-300000749251it:ConferencesMemberus-gaap:OperatingSegmentsMember2023-04-012023-06-300000749251us-gaap:OperatingSegmentsMemberit:ConsultingMember2023-04-012023-06-300000749251us-gaap:OperatingSegmentsMember2023-04-012023-06-300000749251it:CorporateAndReconcilingItemsMember2023-04-012023-06-300000749251us-gaap:OperatingSegmentsMemberit:ResearchSegmentMember2024-01-012024-06-300000749251it:ConferencesMemberus-gaap:OperatingSegmentsMember2024-01-012024-06-300000749251us-gaap:OperatingSegmentsMemberit:ConsultingMember2024-01-012024-06-300000749251us-gaap:OperatingSegmentsMember2024-01-012024-06-300000749251it:CorporateAndReconcilingItemsMember2024-01-012024-06-300000749251us-gaap:OperatingSegmentsMemberit:ResearchSegmentMember2023-01-012023-06-300000749251it:ConferencesMemberus-gaap:OperatingSegmentsMember2023-01-012023-06-300000749251us-gaap:OperatingSegmentsMemberit:ConsultingMember2023-01-012023-06-300000749251us-gaap:OperatingSegmentsMember2023-01-012023-06-300000749251it:CorporateAndReconcilingItemsMember2023-01-012023-06-300000749251srt:MaximumMember2024-01-012024-06-300000749251it:A2024CreditAgreementMemberus-gaap:UnsecuredDebtMemberus-gaap:RevolvingCreditFacilityMember2024-06-300000749251it:A2024CreditAgreementMemberus-gaap:UnsecuredDebtMemberus-gaap:RevolvingCreditFacilityMember2023-12-310000749251it:A2020CreditAgreementMemberit:TermLoanFacilityMember2024-06-300000749251it:A2020CreditAgreementMemberit:TermLoanFacilityMember2023-12-310000749251it:A2020CreditAgreementMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2024-06-300000749251it:A2020CreditAgreementMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2023-12-310000749251us-gaap:SeniorNotesMemberit:SeniorNotesDue2028Member2024-06-300000749251us-gaap:SeniorNotesMemberit:SeniorNotesDue2028Member2023-12-310000749251it:SeniorNotesDue2029Memberus-gaap:SeniorNotesMember2023-12-310000749251it:SeniorNotesDue2029Memberus-gaap:SeniorNotesMember2024-06-300000749251us-gaap:SeniorNotesMemberit:SeniorNotesDue2030Member2024-06-300000749251us-gaap:SeniorNotesMemberit:SeniorNotesDue2030Member2023-12-310000749251it:OtherLongTermDebtMember2024-06-300000749251it:OtherLongTermDebtMember2023-12-310000749251it:A2024CreditAgreementMemberus-gaap:UnsecuredDebtMemberus-gaap:RevolvingCreditFacilityMember2024-01-012024-06-300000749251it:ConnecticutEconomicDevelopmentProgramMemberit:EconomicDevelopmentLoan2Member2024-01-012024-06-300000749251it:ConnecticutEconomicDevelopmentProgramMemberit:EconomicDevelopmentLoan2Member2024-06-300000749251it:A2024CreditAgreementMemberus-gaap:UnsecuredDebtMemberus-gaap:RevolvingCreditFacilityMember2024-03-260000749251it:A2024CreditAgreementMemberus-gaap:UnsecuredDebtMemberus-gaap:RevolvingCreditFacilityMember2024-03-262024-03-260000749251it:A2024CreditAgreementMemberus-gaap:LetterOfCreditMemberus-gaap:UnsecuredDebtMember2024-03-260000749251it:A2024CreditAgreementMemberus-gaap:UnsecuredDebtMemberit:VariableRateComponentOneMemberus-gaap:RevolvingCreditFacilityMember2024-01-012024-06-300000749251it:A2024CreditAgreementMemberit:VariableRateComponentTwoMemberus-gaap:UnsecuredDebtMemberus-gaap:RevolvingCreditFacilityMembersrt:MinimumMember2024-03-262024-03-260000749251it:A2024CreditAgreementMembersrt:MaximumMemberit:VariableRateComponentTwoMemberus-gaap:UnsecuredDebtMemberus-gaap:RevolvingCreditFacilityMember2024-03-262024-03-260000749251it:A2024CreditAgreementMemberus-gaap:UnsecuredDebtMemberus-gaap:RevolvingCreditFacilityMembersrt:MinimumMember2024-03-262024-03-260000749251it:A2024CreditAgreementMembersrt:MaximumMemberus-gaap:UnsecuredDebtMemberus-gaap:RevolvingCreditFacilityMember2024-03-262024-03-260000749251it:SeniorNotesDue2029Memberus-gaap:SeniorNotesMember2021-06-180000749251it:SeniorNotesDue2029Memberus-gaap:SeniorNotesMemberit:DebtInstrumentRedemptionOptionOneMember2021-06-182021-06-180000749251us-gaap:SeniorNotesMemberit:SeniorNotesDue2030Member2020-09-280000749251us-gaap:SeniorNotesMemberit:SeniorNotesDue2030Member2020-09-282020-09-280000749251us-gaap:SeniorNotesMemberit:SeniorNotesDue2028Member2020-06-220000749251us-gaap:SeniorNotesMemberit:SeniorNotesDue2028Member2020-06-222020-06-220000749251it:A2020CreditAgreementMemberit:TermLoanFacilityMember2024-03-250000749251it:A2020CreditAgreementMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2024-03-250000749251us-gaap:InterestRateSwapMemberus-gaap:DebtInstrumentRedemptionPeriodOneMember2024-06-300000749251us-gaap:InterestRateSwapMembersrt:MinimumMember2024-06-300000749251us-gaap:InterestRateSwapMember2024-01-012024-06-300000749251us-gaap:InterestRateSwapMember2024-06-3000007492512015-12-3100007492512021-01-012023-12-310000749251it:OpenMarketPurchasesExcludedMember2024-01-012024-06-300000749251it:OpenMarketPurchasesExcludedMember2023-01-012023-06-300000749251it:OpenMarketPurchasesExcludedMember2024-04-012024-06-300000749251it:OpenMarketPurchasesMember2023-04-012023-06-300000749251it:OpenMarketPurchasesExcludedMember2023-04-012023-06-300000749251us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-03-310000749251us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-03-310000749251us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310000749251us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-04-012024-06-300000749251us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-04-012024-06-300000749251us-gaap:AccumulatedTranslationAdjustmentMember2024-04-012024-06-300000749251us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-06-300000749251us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-06-300000749251us-gaap:AccumulatedTranslationAdjustmentMember2024-06-300000749251us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-03-310000749251us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-03-310000749251us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310000749251us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-04-012023-06-300000749251us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-04-012023-06-300000749251us-gaap:AccumulatedTranslationAdjustmentMember2023-04-012023-06-300000749251us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-06-300000749251us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-06-300000749251us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300000749251us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-310000749251us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310000749251us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000749251us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-012024-06-300000749251us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-06-300000749251us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-06-300000749251us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310000749251us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310000749251us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000749251us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-06-300000749251us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-06-300000749251us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-06-300000749251us-gaap:InterestRateSwapMember2024-04-012024-06-300000749251us-gaap:InterestRateSwapMember2023-04-012023-06-300000749251us-gaap:InterestRateSwapMember2023-01-012023-06-300000749251us-gaap:InterestRateSwapMemberus-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300000749251us-gaap:InterestRateSwapMemberus-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-06-300000749251us-gaap:InterestRateSwapMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-06-300000749251us-gaap:ForeignExchangeForwardMemberit:AccruedLiabilitiesCurrentMemberus-gaap:NondesignatedMember2024-06-300000749251us-gaap:ForeignExchangeForwardMemberit:AccruedLiabilitiesCurrentMemberus-gaap:NondesignatedMember2024-01-012024-06-300000749251us-gaap:InterestRateSwapMemberus-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310000749251us-gaap:InterestRateSwapMemberus-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-12-310000749251us-gaap:InterestRateSwapMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310000749251us-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMemberus-gaap:NondesignatedMember2023-12-310000749251us-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMemberus-gaap:NondesignatedMember2023-01-012023-12-3100007492512023-01-012023-12-310000749251us-gaap:InterestExpenseMember2024-01-012024-06-300000749251us-gaap:InterestExpenseMember2023-04-012023-06-300000749251us-gaap:InterestExpenseMember2024-04-012024-06-300000749251us-gaap:InterestExpenseMember2023-01-012023-06-300000749251us-gaap:OtherNonoperatingIncomeExpenseMember2024-04-012024-06-300000749251us-gaap:OtherNonoperatingIncomeExpenseMember2023-04-012023-06-300000749251us-gaap:OtherNonoperatingIncomeExpenseMember2023-01-012023-06-300000749251us-gaap:OtherNonoperatingIncomeExpenseMember2024-01-012024-06-300000749251us-gaap:FairValueInputsLevel1Memberit:PlanAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2024-06-300000749251us-gaap:FairValueInputsLevel1Memberit:PlanAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000749251us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300000749251us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000749251it:PlanAssetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300000749251it:PlanAssetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000749251us-gaap:ForeignExchangeForwardMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300000749251us-gaap:ForeignExchangeForwardMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000749251us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300000749251us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000749251us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300000749251us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000749251us-gaap:FairValueMeasurementsRecurringMember2024-06-300000749251us-gaap:FairValueMeasurementsRecurringMember2023-12-310000749251it:PlanLiabilitiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300000749251it:PlanLiabilitiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000749251us-gaap:FairValueInputsLevel2Memberus-gaap:SeniorNotesMemberit:SeniorNotesDue2028Member2024-06-300000749251us-gaap:FairValueInputsLevel2Memberus-gaap:SeniorNotesMemberit:SeniorNotesDue2028Member2023-12-310000749251it:SeniorNotesDue2029Memberus-gaap:FairValueInputsLevel2Memberus-gaap:SeniorNotesMember2024-06-300000749251it:SeniorNotesDue2029Memberus-gaap:FairValueInputsLevel2Memberus-gaap:SeniorNotesMember2023-12-310000749251us-gaap:FairValueInputsLevel2Memberus-gaap:SeniorNotesMemberit:SeniorNotesDue2030Member2024-06-300000749251us-gaap:FairValueInputsLevel2Memberus-gaap:SeniorNotesMemberit:SeniorNotesDue2030Member2023-12-310000749251us-gaap:SeniorNotesMember2024-06-300000749251us-gaap:SeniorNotesMember2023-12-310000749251us-gaap:FairValueInputsLevel2Memberus-gaap:SeniorNotesMember2024-06-300000749251us-gaap:FairValueInputsLevel2Memberus-gaap:SeniorNotesMember2023-12-310000749251it:RightOfUseAssetsMember2023-04-012023-06-300000749251us-gaap:LeaseholdImprovementsMember2023-04-012023-06-300000749251it:RightOfUseAssetsMember2024-01-012024-06-300000749251it:RightOfUseAssetsMember2023-01-012023-06-300000749251us-gaap:LeaseholdImprovementsMember2024-01-012024-06-300000749251us-gaap:LeaseholdImprovementsMember2023-01-012023-06-300000749251us-gaap:SubsequentEventMember2024-07-252024-07-250000749251us-gaap:SubsequentEventMember2024-07-25


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
For the quarterly period ended June 30, 2024
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 1-14443
Gartner, Inc.
(Exact name of Registrant as specified in its charter)
Delaware04-3099750
(State or other jurisdiction of(I.R.S. Employer
incorporation or organization)Identification Number)
  
P.O. Box 1021206902-7700
56 Top Gallant Road(Zip Code)
Stamford, 
Connecticut
(Address of principal executive offices) 
Registrant’s telephone number, including area code: (203) 964-0096
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, $.0005 par value per shareITNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer Accelerated filerNon-accelerated filer
Smaller reporting company Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No
As of July 26, 2024, 77,059,514 shares of the registrant’s common shares were outstanding.
1


Table of Contents

 Page
 
 
PART II. OTHER INFORMATION
 

2


PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

GARTNER, INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(Unaudited; in thousands, except share data)
 June 30,December 31,
20242023
Assets  
Current assets:  
Cash and cash equivalents$1,235,785 $1,318,999 
Fees receivable, net of allowances of $9,000 for both periods
1,404,321 1,601,228 
Deferred commissions320,687 380,479 
Prepaid expenses and other current assets147,922 127,180 
Total current assets3,108,715 3,427,886 
Property, equipment and leasehold improvements, net258,450 262,718 
Operating lease right-of-use assets339,805 366,809 
Goodwill2,934,222 2,937,260 
Intangible assets, net455,021 501,958 
Other assets334,496 339,288 
Total Assets$7,430,709 $7,835,919 
Liabilities and Stockholders’ Equity   
Current liabilities:  
Accounts payable and accrued liabilities$835,287 $1,127,604 
Deferred revenues2,626,511 2,640,515 
Current portion of long-term debt 9,600 
Total current liabilities3,461,798 3,777,719 
Long-term debt, net of deferred financing fees 2,457,872 2,448,696 
Operating lease liabilities471,553 513,406 
Other liabilities392,827 415,464 
Total Liabilities6,784,050 7,155,285 
Stockholders’ Equity   
Preferred stock, $0.01 par value, 5,000,000 shares authorized; none issued or outstanding
  
Common stock, $0.0005 par value, 250,000,000 shares authorized; 163,602,067 shares issued for both periods
82 82 
Additional paid-in capital2,421,835 2,320,289 
Accumulated other comprehensive loss, net(81,653)(76,331)
Accumulated earnings5,179,385 4,739,292 
Treasury stock, at cost, 86,106,177 and 85,264,526 common shares, respectively
(6,872,990)(6,302,698)
Total Stockholders’ Equity 646,659 680,634 
Total Liabilities and Stockholders’ Equity $7,430,709 $7,835,919 
 

See the accompanying notes to Condensed Consolidated Financial Statements.
3


GARTNER, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Operations
(Unaudited; in thousands, except per share data)
Three Months EndedSix Months Ended
 June 30,June 30,
 2024202320242023
Revenues:
Research$1,265,992 $1,207,885 $2,534,164 $2,425,076 
Conferences186,084 168,897 256,153 233,539 
Consulting142,984 126,403 277,669 253,439 
Total revenues1,595,060 1,503,185 3,067,986 2,912,054 
Costs and expenses:
Cost of services and product development513,314 487,418 972,755 922,557 
Selling, general and administrative712,071 680,168 1,401,904 1,337,258 
Depreciation27,594 23,712 53,911 47,608 
Amortization of intangibles22,940 22,901 45,930 45,636 
Acquisition and integration charges358 1,973 818 3,341 
    Gain from sale of divested operation 3,906  (135,410)
Total costs and expenses1,276,277 1,220,078 2,475,318 2,220,990 
Operating income 318,783 283,107 592,668 691,064 
Interest expense, net(19,990)(24,558)(39,209)(51,949)
Gain on event cancellation insurance claims   3,077 
Other income, net504 5,575 5,395 3,209 
Income before income taxes299,297 264,124 558,854 645,401 
Provision for income taxes69,749 66,081 118,761 151,575 
Net income $229,548 $198,043 $440,093 $493,826 
Net income per share: 
Basic$2.95 $2.50 $5.64 $6.22 
Diluted$2.93 $2.48 $5.60 $6.17 
Weighted average shares outstanding:
Basic77,816 79,285 78,078 79,368 
Diluted78,288 79,820 78,651 80,015 

See the accompanying notes to Condensed Consolidated Financial Statements.
4


GARTNER, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Comprehensive Income
(Unaudited; in thousands)
Three Months EndedSix Months Ended
 June 30,June 30,
 2024202320242023
Net income $229,548 $198,043 $440,093 $493,826 
Other comprehensive income (loss), net of tax: 
Foreign currency translation adjustments(2,967)6,932 (12,674)8,764 
Interest rate swaps – net change in deferred gain or loss3,649 3,818 7,250 7,652 
Pension plans – net change in deferred actuarial loss51 33 102 67 
Other comprehensive income (loss), net of tax733 10,783 (5,322)16,483 
Comprehensive income$230,281 $208,826 $434,771 $510,309 

See the accompanying notes to Condensed Consolidated Financial Statements.
5


GARTNER, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Changes in Stockholders’ Equity
(Unaudited; in thousands)


Three and Six Months Ended June 30, 2024
Common StockAdditional Paid-In CapitalAccumulated Other Comprehensive Loss, NetAccumulated EarningsTreasury StockTotal
Balance at December 31, 2023$82 $2,320,289 $(76,331)$4,739,292 $(6,302,698)$680,634 
Net income— — — 210,545 — 210,545 
Other comprehensive income— — (6,055)— — (6,055)
Issuances under stock plans— 2,712 — — 5,360 8,072 
Common share repurchases (including excise tax)— — — — (225,522)(225,522)
Stock-based compensation expense — 50,500 — — — 50,500 
Balance at March 31, 2024$82 $2,373,501 $(82,386)$4,949,837 $(6,522,860)$718,174 
Net income— — — 229,548 — 229,548 
Other comprehensive loss— — 733 — — 733 
Issuances under stock plans— 8,587 — — (2,161)6,426 
Common share repurchases (including excise tax)— — — — (347,969)(347,969)
Stock-based compensation expense— 39,747 — — — 39,747 
Balance at June 30, 2024$82 $2,421,835 $(81,653)$5,179,385 $(6,872,990)$646,659 

Three and Six Months Ended June 30, 2023
Common StockAdditional Paid-In CapitalAccumulated Other Comprehensive Loss, NetAccumulated EarningsTreasury StockTotal
Balance at December 31, 2022$82 $2,179,604 $(101,610)$3,856,826 $(5,707,104)$227,798 
Net income— — — 295,783 — 295,783 
Other comprehensive loss— — 5,700 — — 5,700 
Issuances under stock plans— (2,141)— — 9,520 7,379 
Common share repurchases— — — — (108,850)(108,850)
Stock-based compensation expense — 45,048 — — — 45,048 
Balance at March 31, 2023$82 $2,222,511 $(95,910)$4,152,609 $(5,806,434)$472,858 
Net income— — — 198,043 — 198,043 
Other comprehensive loss— — 10,783 — — 10,783 
Issuances under stock plans— 4,313 — — 1,586 5,899 
Common share repurchases (including excise tax)— — — — (133,310)(133,310)
Stock-based compensation expense— 32,233 — — — 32,233 
Balance at June 30, 2023$82 $2,259,057 $(85,127)$4,350,652 $(5,938,158)$586,506 

See the accompanying notes to Condensed Consolidated Financial Statements.
6


GARTNER, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(Unaudited; in thousands)
Six Months Ended
 June 30,
 20242023
Operating activities:  
Net income $440,093 $493,826 
Adjustments to reconcile net income to cash provided by operating activities:  
Depreciation and amortization 99,841 93,244 
Stock-based compensation expense90,247 77,281 
Deferred taxes3,091 (16,153)
Gain from sale of divested operation (135,410)
Loss on impairment of lease related assets527 18,727 
Reduction in the carrying amount of operating lease right-of-use assets32,167 35,357 
Amortization and write-off of deferred financing fees2,548 2,330 
     Gain on de-designated swaps
(5,038)(5,101)
Changes in assets and liabilities, net of acquisitions and divestitures:  
Fees receivable, net172,907 294,569 
Deferred commissions55,063 54,053 
Prepaid expenses and other current assets(22,525)(18,667)
Other assets(28,533)(30,738)
Deferred revenues15,935 36,704 
Accounts payable and accrued and other liabilities(297,523)(299,561)
Cash provided by operating activities558,800 600,461 
Investing activities:  
Additions to property, equipment and leasehold improvements(52,027)(46,694)
Acquisition of business
(2,000) 
Proceeds from sale of divested operation 156,057 
Cash (used in) provided by investing activities(54,027)109,363 
Financing activities:  
Proceeds from employee stock purchase plan14,460 13,240 
Payments of deferred financing fees(2,972) 
Proceeds from revolving credit facility274,400  
Payments on long-term debt
(274,400)(3,600)
Purchases of treasury stock(564,717)(238,372)
Cash used in financing activities(553,229)(228,732)
Net (decrease) increase in cash and cash equivalents and restricted cash(48,456)481,092 
Effects of exchange rates on cash and cash equivalents(35,358)(6,263)
Cash and cash equivalents and restricted cash, beginning of period 1,319,599 698,599 
Cash and cash equivalents and restricted cash, end of period $1,235,785 $1,173,428 

See the accompanying notes to Condensed Consolidated Financial Statements.
7


GARTNER, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
 
Note 1 — Business and Basis of Presentation

Business. Gartner, Inc. (NYSE: IT) delivers actionable, objective insight that drives smarter decisions and stronger performance on an organization’s mission-critical priorities.

Segments. Gartner delivers its products and services globally through three business segments: Research, Conferences and Consulting. Revenues and other financial information for the Company’s segments are discussed in Note 7 — Segment Information.

Basis of presentation. The accompanying interim Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”), as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 270 for interim financial information and with the applicable instructions of U.S. Securities and Exchange Commission (“SEC”) Rule 10-01 of Regulation S-X on Form 10-Q, and should be read in conjunction with the consolidated financial statements and related notes of the Company in its Annual Report on Form 10-K for the year ended December 31, 2023.

The fiscal year of Gartner is the twelve-month period from January 1 through December 31. In the opinion of management, all normal recurring accruals and adjustments considered necessary for a fair presentation of financial position, results of operations and cash flows at the dates and for the periods presented herein have been included. The results of operations for the three and six months ended June 30, 2024 may not be indicative of the results of operations for the remainder of 2024 or beyond. When used in these notes, the terms “Gartner,” the “Company,” “we,” “us,” or “our” refer to Gartner, Inc. and its consolidated subsidiaries.

Principles of consolidation. The accompanying interim Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated.

Use of estimates. The preparation of the accompanying interim Condensed Consolidated Financial Statements requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. Such estimates include the valuation of fees receivable, goodwill, intangible assets and other long-lived assets, as well as tax accruals and other liabilities. In addition, estimates are used in revenue recognition, income tax expense or benefit, performance-based compensation charges, depreciation and amortization. Management believes its use of estimates in these interim Condensed Consolidated Financial Statements to be reasonable.

Management continually evaluates and revises its estimates using historical experience and other factors, including the general economic environment and actions it may take in the future. Management adjusts these estimates when facts and circumstances dictate. However, these estimates may involve significant uncertainties and judgments and cannot be determined with precision. In addition, these estimates are based on management’s best judgment at a point in time. As a result, differences between estimates and actual results could be material and would be reflected in the Company’s consolidated financial statements in future periods.

Cash and cash equivalents and restricted cash. Below is a table presenting the beginning-of-period and end-of-period cash amounts from the Company’s Condensed Consolidated Balance Sheets and the total cash amounts presented in the Condensed Consolidated Statements of Cash Flows (in thousands).
June 30,December 31,
20242023
Cash and cash equivalents$1,235,785 $1,318,999 
Restricted cash classified in (1):
Prepaid expenses and other current assets 600 
Cash and cash equivalents and restricted cash $1,235,785 $1,319,599 
(1)Restricted cash consisted of an escrow account established in connection with one of the Company’s business acquisitions. Generally, such cash is restricted to use due to provisions contained in the underlying acquisition agreement. During the
8


three months ended June 30, 2024,the Company paid $0.6 million of restricted cash for deferred consideration related to a 2022 acquisition.

Revenue recognition. Revenue is recognized in accordance with the requirements of FASB ASC Topic 606, Revenue from Contracts with Customers (“ASC Topic 606”). Revenue is only recognized when all of the required criteria for revenue recognition have been met. The accompanying Condensed Consolidated Statements of Operations present revenue net of any sales or value-added taxes that we collect from customers and remit to government authorities. ASC Topic 270 requires certain disclosures in interim financial statements around the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. Note 4 — Revenue and Related Matters provides additional information regarding the Company’s revenues.

Gain on event cancellation insurance claims. In February 2023, the Company received $3.1 million of proceeds related to 2020 event cancellation insurance claims. The Company does not record any gain on insurance claims in excess of expenses incurred until the receipt of the insurance proceeds is deemed to be realizable.

Accounting standards issued but not yet adopted. The FASB has issued accounting standards that have not yet become effective as of June 30, 2024 and may impact the Company’s Consolidated Financial Statements or related disclosures in future periods. The standards and their potential impacts are discussed below.

Income Taxes— In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (“ASU No. 2023-09”). The amendments in this ASU are expected to enhance the transparency and decision usefulness of income tax disclosures. ASU 2023-09 requires entities to enhance income tax disclosures primarily related to the rate reconciliation and income taxes paid information. Companies will need to disaggregate the disclosure of income taxes paid (net of refunds received) by federal, state, and foreign taxes on an annual basis. Additionally, on an annual basis, companies would disclose income taxes paid disaggregated by individual jurisdiction using a quantitative threshold of 5% of total income taxes paid. Public business entities would also be required to provide, on an annual basis, rate reconciliation information by specific categories, including state and local income tax, the effect of cross-border tax laws, foreign tax effects, changes in prior year unrecognized tax benefits, and tax credits, among others. Additionally, some categories would then require disaggregation based on a quantitative threshold of 5%. The foreign tax effect category requires disaggregation by both jurisdiction and nature. The ASU also requires additional qualitative disclosures. All public entities will be required to report income tax information in accordance with the new guidance starting in annual periods beginning after December 15, 2024. The Company expects this ASU to only impact its disclosures with no impacts to the Company’s results of operations, cash flows, and financial condition.

Segment Reporting— In November 2023, the FASB issued ASU 2023-07, Segment Reporting: Improvements in Reportable Segment Disclosures (“ASU No. 2023-07”). The amendments in the ASU are expected to improve disclosures about a public entity’s reportable segments and addresses requests from investors and other allocators of capital for additional, more detailed information about a reportable segment’s expenses. ASU 2023-07 requires public companies to disclose, on an annual and interim basis, significant expenses that are regularly provided to the chief operating decision maker (CODM) and included within each reported measure of segment profit and loss. The amendments in the ASU require that a public company provide all annual disclosures about a reportable segment’s profit or loss and assets currently required under ASC 280 in interim periods. The amendments in the ASU also require that a public entity disclose, on an annual and interim basis, an amount for other segment items by reportable segment and a description of its composition. The other segment items category is the difference between segment revenue less the significant expenses disclosed and each reported measure of segment profit or loss. The amendments in the ASU, among other items, also requires that a public company disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The ASU applies to all public entities that are required to report segment information in accordance with Topic 280. All public entities will be required to report segment information in accordance with the new guidance starting in annual periods beginning after December 15, 2023 and for interim periods within annual periods beginning after December 15, 2024. The Company expects this ASU to only impact its disclosures with no impacts to the Company’s results of operations, cash flows, and financial condition.

Note 2 — Acquisition and Divestiture

Acquisition

In September 2023, the Company acquired 100% of a formerly independent sales agent of Gartner research products in the Czech Republic for an aggregate purchase price of $7.9 million, including cash acquired and deferred consideration. During the
9


six months ended June 30, 2024, the Company paid $2.0 million of deferred consideration. The allocation of the purchase price is preliminary with respect to certain tax matters.

Divestiture

In February 2023, the Company completed the sale of a non-core business, TalentNeuron, for approximately $161.1 million net of post-close adjustments. The Company recorded pre-tax gains of $135.4 million on the sale of TalentNeuron, which is included in Gain from sale of divested operation in the Consolidated Statement of Operations during the six months ended June 30, 2023. TalentNeuron was included in the Company’s Research segment.

Note 3 — Goodwill and Intangible Assets

Goodwill

Goodwill represents the excess of the purchase price of acquired businesses over the estimated fair values of the tangible and identifiable intangible net assets acquired. Evaluations of the recoverability of goodwill are performed in accordance with FASB ASC Topic 350, which requires an annual assessment of potential goodwill impairment at the reporting unit level and whenever events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable.

When performing the annual assessment of the recoverability of goodwill, the Company initially performs a qualitative analysis evaluating whether any events or circumstances occurred or exist that provide evidence that it is more likely than not that the fair value of any of the Company’s reporting units is less than the related carrying amount. If the Company does not believe that it is more likely than not that the fair value of any of the Company’s reporting units is less than the related carrying amount, then no quantitative impairment test is performed. However, if the results of the qualitative assessment indicate that it is more likely than not that the fair value of a reporting unit is less than its respective carrying amount, then a quantitative impairment test is performed. Evaluating the recoverability of goodwill requires judgments and assumptions regarding future trends and events. As a result, both the precision and reliability of the estimates are subject to uncertainty.

The Company’s most recent annual impairment test of goodwill was a qualitative analysis conducted during the quarter ended September 30, 2023 that indicated no impairment. Subsequent to completing the 2023 annual impairment test, there were no events or changes in circumstances noted that required an interim impairment test.

The table below presents changes to the carrying amount of goodwill by segment during the six months ended June 30, 2024 (in thousands).
 ResearchConferencesConsultingTotal
Balance at December 31, 2023 (1)$2,657,549 $183,997 $95,714 $2,937,260 
Foreign currency translation impact (2,789)(43)(206)(3,038)
Balance at June 30, 2024 (1)$2,654,760 $183,954 $95,508 $2,934,222 
(1)The Company does not have any accumulated goodwill impairment losses.

10


Finite-Lived Intangible Assets

The tables below present reconciliations of the carrying amounts of the Company’s finite-lived intangible assets as of the dates indicated (in thousands).
June 30, 2024Customer
Relationships
Technology-relatedOtherTotal
Gross cost at December 31, 2023$1,077,183 $11,200 $10,200 $1,098,583 
Foreign currency translation impact (2,110)  (2,110)
Gross cost1,075,073 11,200 10,200 1,096,473 
Accumulated amortization (1)(623,426)(11,200)(6,826)(641,452)
Balance at June 30, 2024$451,647 $ $3,374 $455,021 
December 31, 2023Customer
Relationships
Technology-relatedOther Total
Gross cost $1,077,183 11,200 $10,200 $1,098,583 
Accumulated amortization (1)(580,937)(9,333)(6,355)(596,625)
Balance at December 31, 2023$496,246 $1,867 $3,845 $501,958 
(1) Finite-lived intangible assets are amortized using the straight-line method over the following periods: Customer relationships—6 to 13 years; Technology-related—3 years; and Other—11 years.

Amortization expense related to finite-lived intangible assets was $22.9 million during both the three months ended June 30, 2024 and 2023, and $45.9 million and $45.6 million during the six months ended June 30, 2024 and 2023, respectively. The estimated future amortization expense by year for finite-lived intangible assets is presented in the table below (in thousands).

2024 (remaining six months)$44,054 
202581,308 
202678,634 
202778,026 
202876,554 
Thereafter96,445 
$455,021 

Note 4 — Revenue and Related Matters

Disaggregated Revenue — The Company’s disaggregated revenue by reportable segment is presented in the tables below for the periods indicated (in thousands).

By Primary Geographic Market (1)

11


Three Months Ended June 30, 2024
Primary Geographic MarketResearchConferencesConsultingTotal
United States and Canada$832,719 $131,119 $90,943 $1,054,781 
Europe, Middle East and Africa287,650 46,629 34,681 368,960 
Other International145,623 8,336 17,360 171,319 
Total revenues $1,265,992 $186,084 $142,984 $1,595,060 
Three Months Ended June 30, 2023
Primary Geographic MarketResearchConferencesConsultingTotal
United States and Canada$812,724 $123,243 $76,413 $1,012,380 
Europe, Middle East and Africa258,255 38,803 33,865 330,923 
Other International136,906 6,851 16,125 159,882 
Total revenues$1,207,885 $168,897 $126,403 $1,503,185 
Six Months Ended June 30, 2024
Primary Geographic MarketResearchConferencesConsultingTotal
United States and Canada$1,667,940 $179,209 $169,482 $2,016,631 
Europe, Middle East and Africa575,193 56,957 71,283 703,433 
Other International291,031 19,987 36,904 347,922 
Total revenues$2,534,164 $256,153 $277,669 $3,067,986 
Six Months Ended June 30, 2023
Primary Geographic MarketResearchConferencesConsultingTotal
United States and Canada$1,622,123 $172,018 $153,388 $1,947,529 
Europe, Middle East and Africa526,912 48,010 66,803 641,725 
Other International276,041 13,511 33,248 322,800 
Total revenues$2,425,076 $233,539 $253,439 $2,912,054 
(1)Revenue is reported based on where the sale is fulfilled.

The Company’s revenue is generated primarily through direct sales to clients by domestic and international sales forces and a network of independent international sales agents.

By Timing of Revenue Recognition

Three Months Ended June 30, 2024
Timing of Revenue RecognitionResearchConferencesConsultingTotal
Transferred over time (1)$1,187,626 $ $106,584 $1,294,210 
Transferred at a point in time (2)78,366 186,084 36,400 300,850 
Total revenues $1,265,992 $186,084 $142,984 $1,595,060 
Three Months Ended June 30, 2023
Timing of Revenue RecognitionResearchConferencesConsultingTotal
Transferred over time (1)$1,113,328 $ $103,921 $1,217,249 
Transferred at a point in time (2)94,557 168,897 22,482 285,936 
Total revenues$1,207,885 $168,897 $126,403 $1,503,185 
12


Six Months Ended June 30, 2024
Timing of Revenue RecognitionResearchConferencesConsultingTotal
Transferred over time (1)$2,369,894 $ $215,171 $2,585,065 
Transferred at a point in time (2)164,270 256,153 62,498 482,921 
Total revenues $2,534,164 $256,153 $277,669 $3,067,986 
Six Months Ended June 30, 2023
Timing of Revenue RecognitionResearchConferencesConsultingTotal
Transferred over time (1)$2,223,124 $ $200,928 $2,424,052 
Transferred at a point in time (2)201,952 233,539 52,511 488,002 
Total revenues$2,425,076 $233,539 $253,439 $2,912,054 
(1)Research revenues in this category are recognized in connection with performance obligations that are satisfied over time using a time-elapsed output method to measure progress. Consulting revenues in this category are recognized over time using costs incurred to date relative to total estimated costs at completion.
(2)The revenues in this category are recognized in connection with performance obligations that are satisfied at the point in time that the contractual deliverables are provided to the customer.

Performance Obligations — For customer contracts that are greater than one year in duration, the aggregate amount of the transaction price allocated to performance obligations that were unsatisfied (or partially unsatisfied) as of June 30, 2024 was approximately $5.6 billion. The Company expects to recognize $1.8 billion, $2.7 billion and $1.1 billion of this revenue (most of which pertains to Research) during the remainder of 2024, the year ending December 31, 2025 and thereafter, respectively. The Company applies a practical expedient that is permitted under ASC Topic 606 and, accordingly, it does not disclose such performance obligation information for customer contracts that have original durations of one year or less. The Company’s performance obligations for contracts meeting this ASC Topic 606 disclosure exclusion primarily include: (i) stand-ready services under Research subscription contracts; (ii) holding conferences and meetings where attendees and exhibitors can participate; and (iii) providing customized Consulting solutions for clients under fixed fee and time and materials engagements. The remaining duration of these performance obligations is generally less than one year, which aligns with the period that the parties have enforceable rights and obligations under the affected contracts.

Customer Contract Assets and Liabilities — The timing of the recognition of revenue and the amount and timing of the Company’s billings and cash collections, including upfront customer payments, result in the recognition of both assets and liabilities on the Company’s Condensed Consolidated Balance Sheets. The table below provides information regarding certain of the Company’s balance sheet accounts that pertain to its contracts with customers (in thousands).

June 30,December 31,
20242023
Assets:
Fees receivable, gross (1)$1,413,321 $1,610,228 
Contract assets recorded in Prepaid expenses and other current assets (2)$29,773 $28,791 
Contract liabilities:
Deferred revenues (current liability) (3)$2,626,511 $2,640,515 
Non-current deferred revenues recorded in Other liabilities (3)25,082 33,490 
Total contract liabilities$2,651,593 $2,674,005 
(1)Fees receivable represent an unconditional right to payment from the Company’s customers and include both billed and unbilled amounts.
(2)Contract assets represent recognized revenue for which the Company does not have an unconditional right to payment as of the balance sheet date because the project may be subject to a progress billing milestone or some other billing restrictions.
(3)Deferred revenues represent amounts (i) for which the Company has received an upfront customer payment or (ii) that pertain to recognized fees receivable. Both situations occur before the completion of the Company’s performance obligation(s).
13



The Company recognized revenue of $1.2 billion during both the three months ended June 30, 2024 and 2023, and $1.7 billion and $1.6 billion during the six months ended June 30, 2024 and 2023, respectively, that was attributable to deferred revenues that were recorded at the beginning of each such period. Those amounts primarily consisted of Research revenues that were recognized ratably as control of the goods or services passed to the customer during the reporting periods. During each of the three and six months ended June 30, 2024 and 2023, the Company did not record any material impairments related to its contract assets.

Note 5 — Computation of Earnings Per Share

Basic earnings per share (“EPS”) is computed by dividing net income by the weighted average number of shares of Common Stock outstanding during the period. Diluted EPS reflects the potential dilution of securities that could share in earnings. Potential shares of common stock are excluded from the computation of diluted earnings per share when their effect would be anti-dilutive.

The table below sets forth the calculation of basic and diluted income per share for the periods indicated (in thousands, except per share data).
Three Months EndedSix Months Ended
 June 30,June 30,
 2024202320242023
Numerator:    
Net income used for calculating basic and diluted income per share$229,548 $198,043 $440,093 $493,826 
Denominator:    
Weighted average common shares used in the calculation of basic income per share 77,816 79,285 78,07879,368
Dilutive effect of outstanding awards associated with stock-based compensation plans (1)472 535 573647
Shares used in the calculation of diluted income per share 78,288 79,820 78,65180,015
Basic income per share$2.95 $2.50 $5.64 $6.22 
Diluted income per share $2.93 $2.48 $5.60 $6.17 
(1)Certain outstanding awards associated with stock-based compensation plans were not included in the computation of diluted income per share because the effect would have been anti-dilutive. These anti-dilutive outstanding awards associated with stock-based compensation plans was approximately 0.1 million for both the three and six months ended June 30, 2024 and approximately 0.2 million for both the three and six months ended June 30, 2023.

Note 6 — Stock-Based Compensation

The Company grants stock-based compensation awards as an incentive for employees and directors to contribute to the Company’s long-term success. The Company currently awards stock-settled stock appreciation rights, service-based and performance-based restricted stock units, and common stock equivalents. As of June 30, 2024, the Company had 5.6 million shares of its common stock, par value $0.0005 per share, (the “Common Stock”) available for stock-based compensation awards under the Gartner, Inc. Long-Term Incentive Plan as amended and restated in June 2023 (the “Plan”).

The tables below summarize the Company’s stock-based compensation expense by award type and expense category line item during the periods indicated (in millions).
Three Months EndedSix Months Ended
 June 30,June 30,
Award type2024202320242023
Stock appreciation rights$3.0 $3.1 $7.6 $5.6 
Restricted stock units36.4 28.9 82.0 71.1 
Common stock equivalents0.3 0.3 0.6 0.6 
Total (1)$39.7 $32.3 $90.2 $77.3 

14


Three Months EndedSix Months Ended
 June 30,June 30,
Expense category line item2024202320242023
Cost of services and product development$15.3 $12.7 $34.8 $31.0 
Selling, general and administrative24.4 19.6 55.4 46.3 
Total (1)$39.7 $32.3 $90.2 $77.3 

(1)Includes costs of $18.4 million and $13.1 million during the three months ended June 30, 2024 and 2023, respectively, and $49.0 million and $39.9 million during the six months ended June 30, 2024 and 2023, respectively, for awards to retirement-eligible employees. Those awards vest on an accelerated basis.

Note 7 — Segment Information

The Company’s products and services are delivered through three segments – Research, Conferences and Consulting, as described below.

Research equips executives and their teams from every function and across all industries with actionable, objective insight, guidance and tools. Our experienced experts deliver all this value informed by an unmatched combination of practitioner-sourced and data-driven research to help our clients address their mission critical priorities.

Conferences provides executives and teams across an organization the opportunity to learn, share and network. From our Gartner Symposium/Xpo series, to industry-leading conferences focused on specific business roles and topics, to peer-driven sessions, our offerings enable attendees to experience the best of Gartner insight and guidance.

Consulting serves senior executives leading technology-driven strategic initiatives leveraging the power of Gartner’s actionable, objective insight. Through custom analysis and on-the-ground support we enable optimized technology investments and stronger performance on our clients’ mission critical priorities.

The Company evaluates segment performance and allocates resources based on gross contribution margin. Gross contribution, as presented in the tables below, is defined as operating income or loss excluding certain Cost of services and product development expenses, Selling, general and administrative expenses, Depreciation, Amortization of intangibles, Acquisition and integration charges and Gain from sale of divested operation. Certain bonus and fringe benefit costs included in consolidated Cost of services and product development are not allocated to segment expense. The accounting policies used by the reportable segments are the same as those used by the Company. There are no intersegment revenues. The Company does not identify or allocate assets, including capital expenditures, by reportable segment. Accordingly, assets are not reported by segment because the information is not available by segment and is not reviewed in the evaluation of segment performance or in making decisions regarding the allocation of resources.

The tables below present information about the Company’s reportable segments for the periods indicated (in thousands).

Three Months Ended June 30, 2024ResearchConferencesConsultingConsolidated
Revenues$1,265,992 $186,084 $142,984 $1,595,060 
Gross contribution933,121 108,112 53,719 1,094,952 
Corporate and other expenses   (776,169)
Operating income   $318,783 
Three Months Ended June 30, 2023ResearchConferencesConsultingConsolidated
Revenues$1,207,885 $168,897 $126,403 $1,503,185 
Gross contribution885,282 98,450 47,321 1,031,053 
Corporate and other expenses(747,946)
Operating income$283,107 

15


Six Months Ended June 30, 2024ResearchConferencesConsultingConsolidated
Revenues$2,534,164 $256,153 $277,669 $3,067,986 
Gross contribution1,877,690 131,367 108,006 2,117,063 
Corporate and other expenses(1,524,395)
Operating income$592,668 
Six Months Ended June 30, 2023ResearchConferencesConsultingConsolidated
Revenues$2,425,076 $233,539 $253,439 $2,912,054 
Gross contribution1,784,796 125,238 98,129 2,008,163 
Corporate and other expenses(1,317,099)
Operating income$691,064 

The table below provides a reconciliation of total segment gross contribution to net income for the periods indicated (in thousands).
Three Months EndedSix Months Ended
June 30,June 30,
2024202320242023
Total segment gross contribution$1,094,952 $1,031,053 $2,117,063 $2,008,163 
Costs and expenses:
Cost of services and product development - unallocated (1)13,206 15,286 21,832 18,666 
Selling, general and administrative 712,071 680,168 1,401,904 1,337,258 
Depreciation and amortization50,534 46,613 99,841 93,244 
Acquisition and integration charges358 1,973 818 3,341 
  Gain from sale of divested operation 3,906  (135,410)
Operating income 318,783 283,107 592,668 691,064 
Interest expense and other, net(19,486)(18,983)(33,814)(48,740)
Gain on event cancellation insurance claims   3,077 
Less: Provision for income taxes69,749 66,081 118,761 151,575 
Net income $229,548 $198,043 $440,093 $493,826 
(1)The unallocated amounts consist of certain bonus and fringe costs recorded in consolidated Cost of services and product development that are not allocated to segment expense. The Company’s policy is to allocate bonuses to segments at 100% of a segment employee’s target bonus. Amounts above or below 100% are absorbed by corporate.

Note 8 — Debt

16


The Company’s total outstanding borrowings are summarized in the table below (in thousands).
June 30,December 31,
Description20242023
2024 Credit Agreement - Revolving facility (1), (2)
$274,400 $ 
2020 Credit Agreement - Term loan facility 274,400 
2020 Credit Agreement - Revolving credit facility  
4.50% Senior Notes due 2028 (“2028 Notes”)
800,000 800,000 
3.625% Senior Notes due 2029 (“2029 Notes”)
600,000 600,000 
3.75% Senior Notes due 2030 (“2030 Notes”)
800,000 800,000 
Other (3)
5,000 5,000 
Principal amount outstanding (4)
2,479,400 2,479,400 
Less: deferred financing fees (5)
(21,528)(21,104)
Net balance sheet carrying amount$2,457,872 $2,458,296 
(1)The contractual annualized interest rate as of June 30, 2024 on the 2024 Credit Agreement was 6.725%, which consisted of Term Secured Overnight Financing Rate (“SOFR”) of 5.375% plus a margin of 1.350%. However, the Company has an interest rate swap contract that effectively converts the floating SOFR on outstanding amounts to a fixed base rate.
(2)The Company had approximately $0.7 billion of available borrowing capacity on the 2024 Credit Agreement revolver (not including the expansion feature) as of June 30, 2024.
(3)Consists of a State of Connecticut economic development loan originated in 2019 with a 10-year maturity and bears interest at a fixed rate of 1.75%. This loan may be repaid at any time by the Company without penalty.
(4)The weighted average annual effective rate on the Company’s outstanding debt for the three and six months ended June 30, 2024, including the effects of its interest rate swaps discussed below, was 5.03% and 5.02%, respectively.
(5)Deferred financing fees are being amortized to Interest expense, net over the term of the related debt obligation.

2024 Credit Agreement

On March 26, 2024, the Company entered into a Credit Agreement (the “2024 Credit Agreement”) among the Company, as borrower, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”).

The 2024 Credit Agreement provides for a $1.0 billion senior unsecured five-year revolving facility. The facility may be increased, at the Company’s option and under certain conditions, by up to an additional $750 million in the aggregate. The facility may be used for revolving loans, and up to $75.0 million may be used for letters of credit. The revolving loans may be borrowed, repaid and re-borrowed until March 26, 2029, at which time all amounts borrowed must be repaid, subject to customary extension mechanics.

On March 26, 2024, the Company borrowed $274.4 million under the 2024 Credit Agreement. The initial borrowing was used to repay the outstanding amounts under the 2020 Credit Agreement. Additional amounts borrowed under the 2024 Credit Agreement will be used for working capital needs and general corporate purposes of the Company and its subsidiaries, including the funding of acquisitions and investments, payment of capital expenditures and the repurchase of shares.

Interest under the revolving facility accrues, at a variable rate, based on, at our option, (i) the Secured Overnight Funding Rate (“SOFR”) plus a credit spread adjustment of 0.10% or (ii) an alternate base rate (“Base Rate”) plus, in each case, an applicable margin, and is payable monthly. The applicable margin ranges between 1.125% and 1.75%, depending on the lower rate determined by either the Company’s leverage ratio or the credit rating of the Company’s senior unsecured debt. At June 30, 2024, the applicable all-in margin on the revolving facility was 1.35% (including the credit spread adjustment). The commitment fee payable on the unused portion of the facility is equal to between 0.125% and 0.25% based on utilization of the facility. The Company has also agreed to pay customary letter of credit fees.

The 2024 Credit Agreement contains certain customary restrictive loan covenants, including, among others, a financial covenant requiring a maximum leverage ratio and covenants limiting the Company’s ability to grant liens, make acquisitions, be acquired and the ability of the Company’s subsidiaries to incur indebtedness. Subsidiaries of the Company are not required to guarantee obligations under the facility, unless such subsidiaries guarantee indebtedness in excess of a threshold set out in the 2024 Credit Agreement, subject to certain limitations and exceptions.
17



The 2024 Credit Agreement contains customary events of default that include, among others, non-payment of principal, interest or fees, material inaccuracy of representations and warranties, violation of covenants, cross defaults to certain other indebtedness, bankruptcy and insolvency events, ERISA defaults, material judgments, and events constituting a change of control. The occurrence of an event of default allows the lenders to terminate their obligations to lend under the 2024 Credit Agreement and could result in the acceleration of the Company’s obligations under the facility.

2029 Notes

On June 18, 2021, the Company issued $600.0 million aggregate principal amount of 3.625% Senior Notes due 2029. The 2029 Notes were issued pursuant to an indenture, dated as of June 18, 2021 (the “2029 Note Indenture”), among the Company, the guarantors party thereto and U.S. Bank National Association, as trustee.

The 2029 Notes were issued at an issue price of 100.0% and bear interest at a rate of 3.625% per annum. Interest on the 2029 Notes is payable on June 15 and December 15 of each year, beginning on December 15, 2021. The 2029 Notes will mature on June 15, 2029.

The Company may redeem some or all of the 2029 Notes at any time on or after June 15, 2024 for cash at the redemption prices set forth in the 2029 Notes Indenture, plus accrued and unpaid interest to, but excluding, the redemption date. Prior to June 15, 2024, the Company may redeem up to 40% of the aggregate principal amount of the 2029 Notes in connection with certain equity offerings, or some or all of the 2029 Notes with a “make-whole” premium, in each case subject to the terms set forth in the 2029 Note Indenture.

On March 26, 2024, in connection with the closing of the 2024 Credit Agreement and as a result of the termination of the 2020 Credit Agreement, the Company’s subsidiaries that guaranteed the Company’s 2029 Notes were released from their guarantee obligations with respect to the Notes, in accordance with the terms of the indenture pursuant to which the 2029 Notes was issued.

2030 Notes

On September 28, 2020, the Company issued $800.0 million aggregate principal amount of 3.75% Senior Notes due 2030. The 2030 Notes were issued pursuant to an indenture, dated as of September 28, 2020 (the “2030 Note Indenture”), among the Company, the guarantors party thereto and U.S. Bank National Association, as trustee.

The 2030 Notes were issued at an issue price of 100.0% and bear interest at a rate of 3.75% per annum. Interest on the 2030 Notes is payable on April 1 and October 1 of each year, beginning on April 1, 2021. The 2030 Notes will mature on October 1, 2030.

The Company may redeem some or all of the 2030 Notes at any time on or after October 1, 2025 for cash at the redemption prices set forth in the 2030 Note Indenture, plus accrued and unpaid interest to, but excluding, the redemption date. Prior to October 1, 2025, the Company may redeem up to 40% of the aggregate principal amount of the 2030 Notes in connection with certain equity offerings, or some or all of the 2030 Notes with a “make-whole” premium, in each case subject to the terms set forth in the 2030 Note Indenture.

On March 26, 2024, in connection with the closing of the 2024 Credit Agreement and as a result of the termination of the 2020 Credit Agreement, the Company’s subsidiaries that guaranteed the Company’s 2030 Notes were released from their guarantee obligations with respect to the Notes, in accordance with the terms of the indenture pursuant to which the 2030 Notes was issued.

2028 Notes

On June 22, 2020, the Company issued $800.0 million aggregate principal amount of 4.50% Senior Notes due 2028. The 2028 Notes were issued pursuant to an indenture, dated as of June 22, 2020 (the “2028 Note Indenture”), among the Company, the guarantors party thereto and U.S. Bank National Association, as trustee.

The 2028 Notes were issued at an issue price of 100.0% and bear interest at a rate of 4.50% per annum. Interest on the 2028 Notes is payable on January 1 and July 1 of each year, beginning on January 1, 2021. The 2028 Notes will mature on July 1, 2028.
18



The Company may redeem some or all of the 2028 Notes at any time on or after July 1, 2023 for cash at the redemption prices set forth in the 2028 Note Indenture, plus accrued and unpaid interest to, but excluding, the redemption date. Prior to July 1, 2023, the Company may redeem up to 40% of the aggregate principal amount of the 2028 Notes in connection with certain equity offerings, or some or all of the 2028 Notes with a “make-whole” premium, in each case subject to the terms set forth in the 2028 Note Indenture.

On March 26, 2024, in connection with the closing of the 2024 Credit Agreement and as a result of the termination of the 2020 Credit Agreement, the Company’s subsidiaries that guaranteed the Company’s 2028 Notes were released from their guarantee obligations with respect to the Notes, in accordance with the terms of the indenture pursuant to which the 2028 Notes was issued.

2020 Credit Agreement

Prior to entering into the 2024 Credit Agreement, the Company had a credit facility that provided for a $400.0 million Term loan facility and a $1.0 billion Revolving credit facility (the “2020 Credit Agreement”). The 2020 Credit Agreement contained certain customary restrictive loan covenants, including, among others, financial covenants that applied a maximum consolidated leverage ratio and a minimum consolidated interest expense coverage ratio. On March 26, 2024, concurrently with the Company’s entry into the 2024 Credit Agreement, the Company terminated the 2020 Credit Agreement and repaid all amounts outstanding.

Interest Rate Swap

As of June 30, 2024, the Company had one fixed-for-floating interest rate swap contract with a notional value of $350.0 million that matures in September 2025. Under the contract, the Company pays a base fixed rate of 2.98% and in return receives a floating Term SOFR base rate on 30-day notional borrowings.

Effective June 30, 2020, the Company de-designated all of its interest rate swaps and discontinued hedge accounting. Accordingly, subsequent changes to the fair value of the interest rate swap are recorded in Other income, net. The amounts previously recorded in Accumulated other comprehensive loss are amortized into Interest expense, net over the terms of the hedged forecasted interest payments. As of June 30, 2024, $22.6 million is remaining in Accumulated other comprehensive loss, net. See Note 11 — Derivatives and Hedging for the amounts remaining in Accumulated other comprehensive loss, net of tax effect, at June 30, 2024 and December 31, 2023. See Note 12 — Fair Value Disclosures for a discussion of the fair values of Company’s interest rate swaps.

Note 9 — Equity

Share Repurchase Authorization

In 2015, the Company’s Board of Directors (the “Board”) authorized a share repurchase program to repurchase up to $1.2 billion of the Company’s common stock. The Board authorized incremental share repurchases of up to an aggregate additional $3.5 billion of the Company’s common stock during 2021, 2022, and 2023. As of June 30, 2024, $487.8 million remained available under the share repurchase program. The Company may repurchase its common stock from time-to-time in amounts, at prices and in the manner that the Company deems appropriate, subject to the availability of stock, prevailing market conditions, the trading price of the stock, the Company’s financial performance and other conditions. Repurchases may be made through open market purchases (which may include repurchase plans designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended), accelerated share repurchases, private transactions or other transactions and will be funded by cash on hand and borrowings. Repurchases may also be made from time-to-time in connection with the settlement of the Company’s stock-based compensation awards.

The Company’s share repurchase activity is presented in the table below for the periods indicated.
Three Months EndedSix Months Ended
 June 30,June 30,
 2024202320242023
Number of shares repurchased (1) 778,575 423,833 1,268,309 751,513 
Cash paid for repurchased shares (in thousands) (2)$339,593 $131,522 $564,717 $238,372 
19


(1)The average purchase price for repurchased shares was $442.60 and $312.95 for the three months ended June 30, 2024 and 2023, respectively, and $449.19 and $321.34 for the six months ended June 30, 2024 and 2023, respectively. The repurchased shares during the three and six months ended June 30, 2024 and 2023 included purchases for both open market purchases and stock-based compensation award settlements.
(2)The cash paid for repurchased shares during the six months ended June 30, 2024 excluded $5.0 million of open market purchases with trade dates in June 2024 that settled in July 2024 and excise tax accrued. The cash paid for repurchased shares during the six months ended June 30, 2023 excluded $3.1 million of open market purchases with trade dates in June 2023 that settled in July 2023 and excise tax accrued. The cash paid for repurchased shares during the three months ended June 30, 2024 excluded $5.0 million of open market purchases with trade dates in June 2024 that settled in July 2024 and excise tax accrued. The cash paid for repurchased shares during the three months ended June 30, 2023 included $2.0 million of open market purchases with trade dates in March 2023 that settled in April 2023, and excluded $3.1 million of open market purchases with trade dates in June 2023 that settled in July 2023 and excise tax accrued.

Accumulated Other Comprehensive Loss, net (“AOCL”)

The tables below provide information about the changes in AOCL by component and the related amounts reclassified out of AOCL to income during the periods indicated (net of tax, in thousands) (1).

Three Months Ended June 30, 2024
 Interest Rate
Swaps
Defined
Benefit
Pension Plans
Foreign
Currency
Translation
Adjustments
Total
Balance – March 31, 2024$(20,561)$(5,680)$(56,145)$(82,386)
Other comprehensive income (loss) activity during the period:  
  Change in AOCL before reclassifications to income  (2,967)(2,967)
  Reclassifications from AOCL to income (2), (3)3,649 51  3,700 
Other comprehensive income (loss), net3,649 51 (2,967)733 
Balance – June 30, 2024$(16,912)$(5,629)$(59,112)$(81,653)

Three Months Ended June 30, 2023
 Interest Rate
Swaps
Defined
Benefit
Pension Plans
Foreign
Currency
Translation
Adjustments
Total
Balance – March 31, 2023$(35,414)$(4,213)$(56,283)$(95,910)
Other comprehensive income (loss) activity during the period:
  Change in AOCL before reclassifications to income  6,932 6,932 
  Reclassifications from AOCL to income (2), (3)3,818 33  3,851 
Other comprehensive income (loss), net3,818 33 6,932 10,783 
Balance – June 30, 2023$(31,596)$(4,180)$(49,351)$(85,127)

20


Six Months Ended June 30, 2024
Interest Rate
Swaps
Defined
Benefit
Pension Plans
Foreign
Currency
Translation
Adjustments
Total
Balance – December 31, 2023$(24,162)$(5,731)$(46,438)$(76,331)
Other comprehensive income (loss) activity during the period:
  Change in AOCL before reclassifications to income  (12,674)(12,674)
  Reclassifications from AOCL to income (2), (3)7,250 102  7,352 
Other comprehensive income (loss), net7,250 102 (12,674)(5,322)
Balance – June 30, 2024$(16,912)$(5,629)$(59,112)$(81,653)
Six Months Ended June 30, 2023
Interest Rate
Swaps
Defined
Benefit
Pension Plans
Foreign
Currency
Translation
Adjustments